Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
The Presence of Tumor Extrachomosomal Circular Dna (Ecdna) As a Component of Liquid Biopsy in Blood Publisher Pubmed



Khatami F1 ; Larijani B2 ; Tavangar SM1, 3
Authors

Source: Medical Hypotheses Published:2018


Abstract

In molecular biology covalently closed circular DNAs are able to passthrough double layer of eukaryotic cellular membrane. Very recently the presence of circular extra chromosomal DNA (ecDNA) has been shown which are different in seventeen different types of cancers. In fact, ecDNA are the tricky way of oncogenes to increase their copy number. We hypothesis the presence of ecDNA in the blood of cancer patients as a subpopulation of liquid biopsy. On the occasion of their presence in blood they will be very beneficial to cover the small amount of cell frees DNA (cfDNA). Isolation and characterization of ecDNA will be possible by a sensitive method entitled Circle-Seq. The origin of tumor more than its prognosis and diagnosis will be possible in the easiest way by using ecDNA. © 2018
Related Docs
View other Related Docs
1. Liquid Biopsy: The Unique Test for Chasing the Genetics of Solid Tumors, Epigenetics Insights (2020)
2. Liquid Biopsy in Thyroid Cancer: New Insight, International Journal of Hematology-Oncology and Stem Cell Research (2018)
3. Promoter Methylation of Four Tumor Suppressor Genes in Human Papillary Thyroid Carcinoma, Iranian Journal of Pathology (2019)
Experts (# of related papers)
View all Related Experts
Seyed Mohammad Tavangar (15)
Ramin Heshmat (3)
Other Related Docs
4. Circulating Tumor Dna (Ctdna) in the Era of Personalized Cancer Therapy, Journal of Diabetes and Metabolic Disorders (2018)
5. Liquid Biopsy As a Minimally Invasive Source of Thyroid Cancer Genetic and Epigenetic Alterations, International Journal of Molecular and Cellular Medicine (2019)
6. Multiple Endocrine Neoplasia Syndromes From Genetic and Epigenetic Perspectives, Biomarker Insights (2018)
7. Multiple Endocrine Neoplasia Syndromes From Genetic and Epigenetic Perspectives, Biomarker Insights (2018)
8. Adrenal Collision Tumor Composed of Pheochromocytoma and Diffuse Large B-Cell Lymphoma: A Case Report, International Journal of Hematology-Oncology and Stem Cell Research (2018)
9. A Review of Driver Genetic Alterations in Thyroid Cancers, Iranian Journal of Pathology (2018)
10. Genetic and Epigenetic Differences of Benign and Malignant Pheochromocytomas and Paragangliomas (Ppgls), Endocrine Regulations (2018)
11. Genetic and Epigenetic of Medullary Thyroid Cancer, Iranian Biomedical Journal (2018)
12. Cell Free Tumoral Dna Versus Paraffin Block Epidermal Growth Factor Receptor Mutation Detection in Patients With Non-Small Cell Lung Cancer, Asian Pacific Journal of Cancer Prevention (2019)
13. Clear Cell Sarcoma: A Case Report and Review of Literature, International Journal of Hematology-Oncology and Stem Cell Research (2018)
14. Low Expression of Talin1 Is Associated With Advanced Pathological Features in Colorectal Cancer Patients, Scientific Reports (2020)
15. Current Diagnostic Status of Pheochromocytomaand Future Perspective: A Mini Review, Iranian Journal of Pathology (2017)
16. The Emerging Role of Succinate Dehyrogenase Genes (Sdhx) in Tumorigenesis, International Journal of Hematology-Oncology and Stem Cell Research (2019)
17. The Impact of Succinate Dehydrogenase Gene (Sdh) Mutations in Renal Cell Carcinoma (Rcc): A Systematic Review, OncoTargets and Therapy (2019)
18. Oncometabolites: A New Insight for Oncology, Molecular Genetics and Genomic Medicine (2019)
19. Potential Theranostics of Circulating Tumor Cells and Tumor-Derived Exosomes Application in Colorectal Cancer, Cancer Cell International (2020)
20. Oncometabolites As Biomarkers in Thyroid Cancer: A Systematic Review, Cancer Management and Research (2019)